Cardiovascular AI software developer Elucid has appointed Mark Miller as chief revenue officer (CRO). Miller will join the company's leadership team and report to CEO Kelly Huang, PhD.
Miller previously spent a decade at GE HealthCare and Philips, and he served as vice president of sales at Cassling, a regional distribution partner for Siemens Healthineers.
The hire comes ahead of the launch of the company's cardiovascular platform, which combines its U.S. Food and Drug Administration (FDA)-cleared Plaque-IQ software with its BioIntegrated fractional flow reserve-CT software, which is pending FDA clearance.
